Pregnancy as One of the Predictors of Cardiovascular Disease
Review: The effects of pregnancy and adverse pregnancy outcomes (APOs) on cardiovascular disease (CVD) risk. Discussion of CVD rates, statistics & risk factors.
Review: The effects of pregnancy and adverse pregnancy outcomes (APOs) on cardiovascular disease (CVD) risk. Discussion of CVD rates, statistics & risk factors.
Lipids are implicated in the development of coronary atherosclerosis. Achieving a significant reduction in lipid levels remains a crucial aspect of secondary prevention following an…
Over the past few decades, atherogenic dyslipidaemia has become one of the most common phenotypic presentations of lipid abnormalities, being strongly and unequivocally associated with…
For patients experiencing acute coronary syndrome, early symptom recognition is paramount; this is challenging without chest pain presentation. The aims of this scoping review were…
Factor XIa (FXIa) may be involved in thrombus formation, but only to a lesser extent involved in haemostasis. Several novel FXIa inhibitors are under investigation,…
Find out more about antiplatelet treatment with dual pathway inhibition in this free article from ECR Journal. Antiplatelet Treatment with Dual Pathway Inhibition.
Cardiology consultants can find the latest news & information about cardiovascular disease & cardiology conferences by going to Radcliffe cardiology’s website.
Resistant hypertension (RH) is defined as systolic blood pressure (SBP) or diastolic blood pressure (DBP) that remains ≥140 mmHg or ≥90 mmHg, respectively, despite an…
The terms non-alcoholic fatty liver disease and non-alcoholic steatohepatitis have some limitations as they use exclusionary confounder terms and the use of potentially stigmatising
Background: Detection of myocardial bridge (MB) at angiography suggests it has a role in ischaemic-related symptoms in patients with angina without obstructive coronary artery
Background: AF is a global health concern, with systemic complications including renal dysfunction. This systematic review and meta-analysis compares the effects of rivaroxaban, a Factor